Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- D. Boral Capital analyst Jason Kolbert upgraded Plus Therapeutics, Inc. (NASDAQ:PSTV) from Hold to Buy and announced a $5 price target. Plus Therapeutics shares closed …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- D. Boral Capital analyst Jason Kolbert upgraded Plus Therapeutics, Inc. (NASDAQ:PSTV) from Hold to Buy and announced a $5 price target. Plus Therapeutics shares closed …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
D. Boral Capital analyst Jason Kolbert upgraded Plus Therapeutics, Inc. (NASDAQ:PSTV) from Hold to Buy and announced a $5 price target. Plus Therapeutics shares closed …Full story available on Benzinga.com Read MoreBWA, News, PSTV, top upgrades, TRU, Upgrades, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, BWA, US0997241064, TRU, US8910131049, PSTV, News, Upgrades, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
